외용제 포장 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global topical drugs packaging market size is expected to reach USD 38.44 Billion in 2034 from USD 25.60 Billion in 2025, growing at a CAGR of 4.62% during 2026-2034.This market is expected to expand as pharmaceutical companies increase production of creams, ointments, gels, lotions, and other topical formulations. Packaging plays an important role in protecting products from contamination, maintaining formulation stability, and supporting convenient administration. Growing demand for dermatological treatments, pain relief products, and other topical therapies is creating opportunities for packaging manufacturers. Pharmaceutical companies are also seeking packaging formats that provide accurate dispensing and ease of use. These requirements are expected to support continued development of specialized packaging solutions for topical drug applications.

Growth is being driven by increasing pharmaceutical consumption and the continued development of topical therapies for dermatological and other conditions. Tubes, pumps, jars, and specialized dispensing systems are being designed to improve product protection and user convenience. Packaging suppliers are focusing on barrier performance, controlled dispensing, compatibility with formulations, and improved handling characteristics. Regulatory expectations around pharmaceutical packaging quality are also encouraging manufacturers to adopt reliable materials and production processes. As pharmaceutical companies prioritize product safety and patient usability, demand for advanced topical drug packaging is expected to strengthen.

The future outlook remains favorable as pharmaceutical manufacturers increasingly emphasize patient friendly and efficient drug delivery formats. Opportunities are likely to emerge from packaging innovations that improve dosage control, reduce product waste, and provide stronger protection against environmental exposure. Sustainability may also influence future packaging development through greater interest in lightweight materials and responsible manufacturing. The expansion of generic medicines, specialty formulations, and over the counter topical products can broaden the customer base for packaging suppliers. Continued investment in pharmaceutical packaging technology is expected to create new opportunities across established and emerging markets.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Packaging Type

• Flexible packaging
• Rigid packaging
• Semi-rigid packaging

By Packaging Material

• Plastic
• Glass
• Metal
• Paper
• Aluminium
• Others

By Drug Type

• Liquid
• Semi-solid
• Solid
• Transdermal

By Product Types

• Bottles
• Caps & closures
• Inhalers
• Tubes
• Jars
• Others

By Closure Type

• Screw cap
• Flip-top cap
• Pump dispenser
• Dropper
• Nozzle

By Mode of Administration

• Ophthalmic
• Nasal
• Dermal usage

By Application

• Dermatology
• Ophthalmology
• Others

COMPANIES PROFILED

• Amcor plc (Bemis Company, Inc.), AptarGroup, Inc. (Aptar Stelmi), Becton, Dickinson and Company, Berry Global, Inc. (RPC Group), Bormioli Pharma S.p.A., Catalent, Inc., CCL Industries Inc., Constantia Flexibles GmbH, Crown Holdings, Inc., Gerresheimer AG, Hoffmann Neopac AG (Neopac The Tube), Huhtamaki Oyj, Klockner Pentaplast Group, Mondi Group, Nipro Corporation, Nolato AB, Owens-Illinois, Inc., ProAmpac LLC, Sealed Air Corporation, SCHOTT AG, SGD Pharma

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TOPICAL DRUGS PACKAGING MARKET: BY PACKAGING TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Packaging Type
• 4.2. Flexible packaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Rigid packaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Semi-rigid packaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TOPICAL DRUGS PACKAGING MARKET: BY PACKAGING MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Packaging Material
• 5.2. Plastic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Glass Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Metal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Paper Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Aluminium Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TOPICAL DRUGS PACKAGING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Drug Type
• 6.2. Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Semi-solid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Solid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Transdermal Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TOPICAL DRUGS PACKAGING MARKET: BY PRODUCT TYPES 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Product Types
• 7.2. Bottles Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Caps & closures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Inhalers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Jars Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TOPICAL DRUGS PACKAGING MARKET: BY CLOSURE TYPE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Closure Type
• 8.2. Screw cap Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Flip-top cap Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Pump dispenser Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Dropper Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Nozzle Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL TOPICAL DRUGS PACKAGING MARKET: BY MODE OF ADMINISTRATION 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast Mode Of Administration
• 9.2. Ophthalmic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Nasal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Dermal usage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL TOPICAL DRUGS PACKAGING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 10.1. Market Analysis, Insights and Forecast Application
• 10.2. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 10.3. Ophthalmology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 10.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 11. GLOBAL TOPICAL DRUGS PACKAGING MARKET: BY REGION 2022-2034 (USD MN)

• 11.1. Regional Outlook
• 11.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 11.2.1 By Packaging Type
  • 11.2.2 By Packaging Material
  • 11.2.3 By Drug Type
  • 11.2.4 By Product Types
  • 11.2.5 By Closure Type
  • 11.2.6 By Mode Of Administration
  • 11.2.7 By Application
  • 11.2.8 United States
  • 11.2.9 Canada
  • 11.2.10 Mexico
• 11.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 11.3.1 By Packaging Type
  • 11.3.2 By Packaging Material
  • 11.3.3 By Drug Type
  • 11.3.4 By Product Types
  • 11.3.5 By Closure Type
  • 11.3.6 By Mode Of Administration
  • 11.3.7 By Application
  • 11.3.8 United Kingdom
  • 11.3.9 France
  • 11.3.10 Germany
  • 11.3.11 Italy
  • 11.3.12 Spain
  • 11.3.13 Russia
  • 11.3.14 Rest Of Europe
• 11.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 11.4.1 By Packaging Type
  • 11.4.2 By Packaging Material
  • 11.4.3 By Drug Type
  • 11.4.4 By Product Types
  • 11.4.5 By Closure Type
  • 11.4.6 By Mode Of Administration
  • 11.4.7 By Application
  • 11.4.8 China
  • 11.4.9 Japan
  • 11.4.10 South Korea
  • 11.4.11 India
  • 11.4.12 Australia
  • 11.4.13 South East Asia
  • 11.4.14 Rest Of Asia Pacific
• 11.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 11.5.1 By Packaging Type
  • 11.5.2 By Packaging Material
  • 11.5.3 By Drug Type
  • 11.5.4 By Product Types
  • 11.5.5 By Closure Type
  • 11.5.6 By Mode Of Administration
  • 11.5.7 By Application
  • 11.5.8 Brazil
  • 11.5.9 Argentina
  • 11.5.10 Peru
  • 11.5.11 Chile
  • 11.5.12 Rest of Latin America
• 11.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 11.6.1 By Packaging Type
  • 11.6.2 By Packaging Material
  • 11.6.3 By Drug Type
  • 11.6.4 By Product Types
  • 11.6.5 By Closure Type
  • 11.6.6 By Mode Of Administration
  • 11.6.7 By Application
  • 11.6.8 Saudi Arabia
  • 11.6.9 UAE
  • 11.6.10 Israel
  • 11.6.11 South Africa
  • 11.6.12 Rest of the Middle East And Africa

Chapter 12. COMPETITIVE LANDSCAPE

• 12.1. Recent Developments
• 12.2. Company Categorization
• 12.3. Supply Chain & Channel Partners (based on availability)
• 12.4. Market Share & Positioning Analysis (based on availability)
• 12.5. Vendor Landscape (based on availability)
• 12.6. Strategy Mapping

Chapter 13. COMPANY PROFILES OF GLOBAL TOPICAL DRUGS PACKAGING INDUSTRY

• 13.1. Top Companies Market Share Analysis
• 13.2. Company Profiles
  • 13.2.1 Amcor Plc (Bemis Company, Inc.)
  • 13.2.2 AptarGroup, Inc. (Aptar Stelmi)
  • 13.2.3 Becton, Dickinson And Company
  • 13.2.4 Berry Global, Inc. (RPC Group)
  • 13.2.5 Bormioli Pharma S.p.A
  • 13.2.6 CatalentInc
  • 13.2.7 CCL Industries Inc
  • 13.2.8 Constantia Flexibles GmbH
  • 13.2.9 Crown HoldingsInc
  • 13.2.10 Gerresheimer AG
  • 13.2.11 Hoffmann Neopac AG (Neopac The Tube)
  • 13.2.12 Huhtamaki Oyj
  • 13.2.13 Klockner Pentaplast Group
  • 13.2.14 Mondi Group
  • 13.2.15 Nipro Corporation
  • 13.2.16 Nolato AB
  • 13.2.17 Owens-IllinoisInc
  • 13.2.18 ProAmpac LLC
  • 13.2.19 Sealed Air Corporation
  • 13.2.20 SCHOTT AG
  • 13.2.21 SGD Pharma